Piazuelo M Blanca, Camargo M Constanza, Mera Robertino M, Delgado Alberto G, Peek Richard M, Correa Hernan, Schneider Barbara G, Sicinschi Liviu A, Mora Yolanda, Bravo Luis E, Correa Pelayo
Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Hum Pathol. 2008 Sep;39(9):1360-9. doi: 10.1016/j.humpath.2008.01.012. Epub 2008 Jul 9.
Eosinophils and mast cells participate in the immune response against Helicobacter pylori, but their involvement in the gastric precancerous process is unclear. This study aimed to estimate eosinophil and mast cell density in antral mucosa in subjects from 2 Colombian populations with contrasting gastric cancer risks. Gastric mucosa biopsies were collected from 117 adult males (72 from a high-risk area and 45 from a low-risk area). A histopathology score was used to quantify severity of the lesions. Quantitation of eosinophils in hematoxylin-eosin-stained sections and mast cells in immunostained sections for CD117/c-Kit was performed. Helicobacter pylori infection and genotyping were assessed in Steiner stain and polymerase chain reaction, respectively. Logistic regression models and semiparametric cubic smoothing splines were used for analysis of the results. Eosinophil density was significantly higher in subjects from the low-risk area as compared with subjects from the high-risk area. In both populations, eosinophil density increased with the histopathology score in the progression of lesions from normal morphology to multifocal atrophic gastritis. Intestinal metaplasia and dysplasia specimens showed further increase in eosinophil density in the high-risk area but an abrupt decrease in the low-risk area. Mast cell density increased in parallel to the histopathology score in both populations. Our results suggest that eosinophils play a dual role in chronic gastritis. In the low-risk area, elevated eosinophil density represents a T helper 2-biased response that may down-regulate the effects of proinflammatory cytokines preventing cancer development. In contrast, in the high-risk area, eosinophils might promote a T helper 1-type response leading to progression of precancerous lesions.
嗜酸性粒细胞和肥大细胞参与针对幽门螺杆菌的免疫反应,但其在胃癌前期过程中的作用尚不清楚。本研究旨在评估来自两个胃癌风险不同的哥伦比亚人群的胃窦黏膜中嗜酸性粒细胞和肥大细胞的密度。从117名成年男性中收集胃黏膜活检样本(72名来自高风险地区,45名来自低风险地区)。使用组织病理学评分来量化病变的严重程度。对苏木精-伊红染色切片中的嗜酸性粒细胞以及CD117/c-Kit免疫染色切片中的肥大细胞进行定量分析。分别采用施泰纳染色和聚合酶链反应评估幽门螺杆菌感染和基因分型。使用逻辑回归模型和半参数三次平滑样条对结果进行分析。与高风险地区的受试者相比,低风险地区受试者的嗜酸性粒细胞密度显著更高。在这两个人群中,随着病变从正常形态发展为多灶性萎缩性胃炎,嗜酸性粒细胞密度均随组织病理学评分增加。肠化生和发育异常标本显示,高风险地区的嗜酸性粒细胞密度进一步增加,而低风险地区则急剧下降。在两个人群中,肥大细胞密度均与组织病理学评分平行增加。我们的结果表明,嗜酸性粒细胞在慢性胃炎中发挥双重作用。在低风险地区,嗜酸性粒细胞密度升高代表一种以辅助性T细胞2为主的反应,可能下调促炎细胞因子的作用,从而预防癌症发展。相反,在高风险地区,嗜酸性粒细胞可能促进辅助性T细胞1型反应,导致癌前病变进展。